Hoarseness (Dysphonia)

- References

1. Seth R. Schwartz, et al. Clinical practice guideline: Hoarseness (Dysphonia) Otolaryngol Head Neck Surg 2009;141:S1-S31.

2. Robert J. Stachler, et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update) Otolaryngol

Head Neck Surg 2018;158:S1–S42.

3. Brouha XD, Tromp DM, de Leeuw JR, et al. Laryngeal cancer patients: analysis of patient delay at different tumor stages. Head Neck 2005;27:289–95.

4. Scott S, Robinson K, Wilson JA, et al. Patient-reported problems associated with dysphonia. Clin Otolaryngol Allied Sci 1997;22:37– 40.

5. Zur KB, Cotton S, Kelchner L, et al. Pediatric Voice Handicap Index (pVHI): a new tool for evaluating pediatric dysphonia. Int J Pediatr Otorhinolaryngol 2007;71:77–82.

6. Yeung P, Erskine C, Mathews P, et al. Voice changes and thyroid surgery: is pre-operative indirect laryngoscopy necessary? Aust N Z J Surg 1999;69:632–4.

7. Moulton-Barrett R, Crumley R, Jalilie S, et al. Complications of thyroid surgery. Int Surg 1997;82:63–6.

8. Baba M, Natsugoe S, Shimada M, et al. Does hoarseness of voice from recurrent nerve paralysis after esophagectomy for carcinoma influence patient quality of life? J Am Coll Surg 1999;188:231–6.

9. Morris GL III, Mueller WM. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999;53:1731–5.

10. Santos PM, Afrassiabi A, Weymuller EA Jr. Risk factors associated with prolonged intubation and laryngeal injury. Otolaryngol Head Neck Surg 1994;111:453–9.

11. Mace SE. Blunt laryngotracheal trauma. Ann Emerg Med 1986;15:836–42.

12. Schaefer SD. The acute management of external laryngeal trauma. A 27-year experience. Arch Otolaryngol Head Neck Surg 1992;118:598–604.

13. Resouly A, Hope A, Thomas S. A rapid access husky voice clinic: useful in diagnosing laryngeal pathology. J Laryngol Otol 2001;115:978–80.

14. Johnson JT, Newman RK, Olson JE. Persistent hoarseness: an aggressive approach for early detection of laryngeal cancer. Postgrad Med 1980;67:122–6.

15. Hartl DA, Hans S, Vaissière J, et al. Objective acoustic and aerodynamic measures of breathiness in paralytic dysphonia. Eur Arch Otorhinolaryngol 2003;260:175–82.

16. Faust RA. Childhood voice disorders: ambulatory evaluation and operative diagnosis. Clin Pediatr 2003;42:1–9.

17. Portier F, Marianowski R, Morisseau-Durand MP, et al. Respiratory obstruction as a sign of brainstem dysfunction in infants with Chiari malformations. Int J Pediatr Otorhinolaryngol 2001;57:195–202.

18. Truong MT, Messner AH, Kerschner JE, et al. Pediatric vocal fold paralysis after cardiac surgery: rate of recovery and sequelae. Otolaryngol Head Neck Surg 2007;137:780–4.

19. Dworkin JP. Laryngitis: types, causes, and treatments. Otolaryngol Clin North Am 2008;41:419–36, ix.

20. Wang CL, Cohan RH, Ellis JH, et al. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. Am J Roentgenol 2008;191:409–15.

21. Mortelé KJ, Oliva MR, Ondategui S, et al. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 2005;184:31–4.

22. Dillman JR, Ellis JH, Cohan RH, et al. Frequency and severity of acute allergic-like reactions to gadolinium-containing IV contrast media in children and adults. AJR Am J Roentgenol 2007;189: 1533–8.

23. Chung SM. Safety issues in magnetic resonance imaging. J Neuroophthalmol 2002;22:35–9.

24. Stecco A, Saponaro A, Carriero A. Patient safety issues in magnetic resonance imaging: state of the art. Radiol Med 2007;112:491–508.

25. Quirk ME, Letendre AJ, Ciottone RA, et al. Anxiety in patients undergoing MR imaging. Radiology 1989;170:463–6.

26. Belafsky PC, Postma GN, Koufman JA. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001;111:979–81.

27. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001;96:979–83.

28. Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006;116: 254 – 60.

29. Hanlon JT, Landerman LR, Artz MB, et al. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. Pharmacoepidemiol Drug Saf 2004;13:781–7.

30. Ylitalo R, Ramel S. Extraesophageal reflux in patients with contact granuloma: a prospective controlled study. Ann Otol Rhinol Laryngol 2002;111:441–6.

31. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230–8.

32. Williams AJ, Baghat MS, Stableforth DE, et al. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983;38:813–21.

33. Williamson IJ, Matusiewicz SP, Brown PH, et al. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995;8:590–2.

34. Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD000247. DOI: 10.1002/14651858.CD000247.pub2.

35. Glasziou PP, Del Mar C, Sanders S, et al. Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD000219. DOI: 10.1002/14651858. CD000219.pub2.

36. Horn JR, Hansten PD. Drug interactions with antibacterial agents. J Fam Pract 1995;41:81–90.

37. Royal College of Speech & Language Therapists. Clinical voice disorders. Royal College of Speech & Language Therapists; 2005. http://www.rcslt.org/resources/RCSLT_Clinical_Guidelines.pdf (accessed June 10, 2009).

38. American Speech-Language-Hearing Association. Preferred practice patterns for the profession of speech-language pathology. 2004. http://www.asha.org/docs/html/PP2004-00191.html.

39. Bastian RW, Levine LA. Visual methods of office diagnosis of voice disorders. Ear Nose Throat J 1988;67:363–79.

40. American Speech-Language-Hearing Association. The use of voice therapy in the treatment of dysphonia. 2005. http://www.asha.org/ docs/html/TR2005-00158.html.

41. American Speech-Language-Hearing Association. Training guidelines for laryngeal videoendoscopy/stroboscopy. 1998. http://www.asha.org/docs/html/GL1998-00064.html.

42. Thomas G, Mathews SS, Chrysolyte SB, et al. Outcome analysis of benign vocal cord lesions by videostroboscopy, acoustic analysis and voice handicap index. Indian J Otolaryngol 2007;59:336–40.

43. Zeitels SM, Casiano RR, Gardner GM, et al. Management of common voice problems: committee report. Otolaryngol Head Neck Surg 2002;126:333–48.

44. Johns MM. Update on the etiology, diagnosis, and treatment of vocal fold nodules, polyps, and cysts. Curr Opin Otolaryngol Head Neck Surg 2003;11:456–61.

45. McCrory E. Voice therapy outcomes in vocal fold nodules: a retrospective audit. Int J Lang Commun Disord 2001;36(Suppl):19–24.

46. Havas TE, Priestley J, Lowinger DS. A management strategy for vocal process granulomas. Laryngoscope 1999;109:301–6.

47. Johns MM, Garrett CG, Hwang J, et al. Quality-of-life outcomes following laryngeal endoscopic surgery for non-neoplastic vocal fold lesions. Ann Otol Rhinol Laryngol 2004;113:597–601

48. Sulica L. Contemporary management of spasmodic dysphonia. Curr Opin Otolaryngol Head Neck Surg 2004;12:543–8.

49. Stong BC, DelGaudio JM, Hapner ER, et al. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia. Arch Otolaryngol Head Neck Surg 2005;131:793–5.

50. Troung DD, Rontal M, Rolnick M, et al. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia. Laryngoscope 1991;101:630–4.

51. Cannito MP, Woodson GE, Murry T, et al. Perceptual analyses of spasmodic dysphonia before and after treatment. Arch Otolaryngol Head Neck Surg 2004;130:1393–9.

52. Courey MS, Garrett CG, Billante CR, et al. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin. Ann Otol Rhinol Laryngol 2000;109:819–22.

53. Yiu EM, Chan RM. Effect of hydration and vocal rest on the vocal fatigue in amateur karaoke singers. J Voice 2003;17:216–27.

54. Jónsdottir V, Laukkanen AM, Siikki I. Changes in teachers’ voice quality during a working day with and without electric sound amplification. Folia Phoniatr Logop 2003;55:267–80.

55. Ruotsalainen JH, Sellman J, Lehto L, et al. Interventions for preventing voice disorders in adults. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006372. DOI: 10.1002/14651858.

56. Duffy OM, Hazlett DE. The impact of preventive voice care programs for training teachers: a longitudinal study. J Voice 2004;18:63–70.

57. Bovo R, Galceran M, Petruccelli J, et al. Vocal problems among teachers: evaluation of a preventive voice program. J Voice 2007;21:705–22.